Deciphera Pharmaceuticals Inc (DCPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 163,356 | 134,036 | 96,148 | 42,087 | 25,000 |
| Cost of Goods | 3,732 | 8,770 | 2,932 | 225 | N/A |
| Gross Profit | 159,624 | 125,266 | 93,216 | 41,862 | 25,000 |
| Operating Expenses | 371,314 | 308,758 | 394,225 | 313,277 | 225,726 |
| Operating Income | -210,958 | -182,722 | -300,077 | -271,190 | -200,726 |
| Interest Expense | 0 | 0 | 0 | 0 | 67 |
| Other Income | 16,447 | 4,513 | 113 | 4,701 | 8,537 |
| Pre-tax Income | -194,511 | -178,209 | -299,964 | -266,489 | -192,256 |
| Income Tax | 431 | 722 | N/A | N/A | N/A |
| Net Income Continuous | -194,942 | -178,931 | -299,964 | -266,489 | -192,256 |
| Net Income | $-194,942 | $-178,931 | $-299,964 | $-266,489 | $-192,256 |
| EPS Basic Total Ops | -2.29 | -2.37 | -5.16 | -4.78 | -4.48 |
| EPS Basic Continuous Ops | -2.29 | -2.37 | -5.16 | -4.78 | -4.48 |
| EPS Diluted Total Ops | -2.29 | -2.37 | -5.16 | -4.78 | -4.48 |
| EPS Diluted Continuous Ops | -2.29 | -2.37 | -5.16 | -4.78 | -4.48 |
| EPS Diluted Before Non-Recurring Items | -2.29 | -2.37 | -5.16 | -4.78 | -4.48 |
| EBITDA(a) | $-208,858 | $-179,776 | $-297,063 | $-268,885 | $-199,896 |